Kaposi sarcoma, primary site

International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01

A malignant neoplasm characterised by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).

sections/codes in this section (2B57-2B57)

• Kaposi sarcoma of lung  (2B57.0)
• Kaposi sarcoma of skin  (2B57.1)
• Kaposi sarcoma of gastrointestinal sites  (2B57.2)
• Kaposi sarcoma of other specified primary sites  (2B57.Y)
• Kaposi sarcoma of unspecified primary site  (2B57.Z)

Thank you for choosing Find-A-Code, please Sign In to remove ads.